Advertisement
Advertisement
LITS
L
Lite Strategy, Inc. Common Stock
1.19
USDSponsored
-0.06
-4.88%
May 13, 15:58 UTC -4
Closed
After-Market
1.19
0.00
0.00%
LITS Earnings Reports
Positive Surprise Ratio
LITS beat 26 of 34 last estimates.
76%
Next Report
Today
Date of Next Report
May 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Lite Strategy, Inc. Common Stock earnings per share and revenue
On Feb 10, 2026, LITS reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioVie, Inc. Common Stock
Report Date
May 11, 2026 For Q3 26
Estimate
-$0.74
Actual
-$0.70
Surprise
+5.99%
Harrow, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.40
Actual
-$0.63
Surprise
-53.85%
Relmada Therapeutics, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.22
Surprise
-10.61%
Altimmune, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.24
Actual
-$0.18
Surprise
+27.18%
Prelude Therapeutics Incorporated
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.13
Surprise
+48.68%
Inhibikase Therapeutics, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.59%
Achieve Life Sciences, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.19
Surprise
+39.59%
Heron Therapeutics, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.01
Actual
-$0.04
Surprise
-161.44%
Verrica Pharmaceuticals Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.41
Surprise
-5.92%
PolyPid Ltd. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.44
Actual
-$0.35
Surprise
+20.81%
FAQ
What were Lite Strategy, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Lite Strategy, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Lite Strategy, Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Lite Strategy, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Lite Strategy, Inc. Common Stock's next earnings report?
Based on --
analysts, Lite Strategy, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement